High drug loading polymer micelle@ZIF-8 hybrid core–shell nanoparticles through donor–receptor coordination interaction for pH/H₂O₂-responsive drug release

Abstract

Smart drug delivery nanocarriers with high drug loading capacity are of great importance in the treatment of diseases, and can improve therapeutic effectiveness as well as alleviate side effects in patients. In this work, a pH and H₂O₂-responsive drug delivery platform with high doxorubicin (DOX) loading capacity has been established through coordination interaction between DOX and phenylboronic acid containing block polymer. A composited drug nanocarrier is further fabricated by growing a zeolitic imidazolate framework 8 (ZIF-8) on the surface of drug-loaded polymer micelles. The study verifies that ZIF-8 shell can act as intelligent “switch” to prevent DOX leaking from core–shell nanoparticles upon H₂O₂ stimulus. However, a burst drug release is detected upon pH and H₂O₂ stimuli due to the further disassociation of ZIF-8 in acid solution. Moreover, the in vitro anti-cancer experiments demonstrate that the DOX-loaded core–shell nanoparticles provide effective treatment towards cancer cells but have negligible effect on normal cells, which results from the high concentration of H₂O₂ and low pH in the microenvironment of tumor cells.

Graphical abstract

Keywords

block copolymer / donor–acceptor / high drug loading capacity / dual responsiveness / controlled drug release

References

[1] Dyba T , Randi G , Bray F . . The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers. European Journal of Cancer, 2021, 157 : 308– 347

[2] Gottesman M M , Fojo T , Bates S E . Multidrug resistance in cancer: role of ATP-dependent transporters. Nature Reviews Cancer, 2002, 2( 1): 48– 58

[3] Jain R K . Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nature Medicine, 2001, 7( 9): 987– 989

[4] Szakács G , Paterson J K , Ludwig J A . . Targeting multidrug resistance in cancer. Nature Reviews Drug Discovery, 2006, 5( 3): 219– 234

[5] DeSantis C E , Lin C C , Mariotto A B . . Cancer treatment and survivorship statistics, 2014. CA: A Cancer Journal for Clinicians, 2014, 64( 4): 252– 271

[6] El-Serag H B . CURRENT CONCEPTS hepatocellular carcinoma. New England Journal of Medicine, 2011, 365( 12): 1118– 1127

[7] Stirrups R . Lapatinib with chemotherapy for gastro-oesophageal cancer. The Lancet Oncology, 2019, 20( 8): e400

[8] Durand R E , Olive P L . Resistance of tumor cells to chemo- and radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids. In: Darzynkiewicz Z, Crissman H A, Robinson J P, eds. Methods in Cell Biology, Vol. 64. Academic Press, 2001, 211– 233

[9] Kaufmann S H , Earnshaw W C . Induction of apoptosis by cancer chemotherapy. Experimental Cell Research, 2000, 256( 1): 42– 49

[10] Wei G , Wang Y , Yang G . . Recent progress in nanomedicine for enhanced cancer chemotherapy. Theranostics, 2021, 11( 13): 6370– 6392

[11] Xiao Q , Zhu W , Feng W . . A review of resveratrol as a potent chemoprotective and synergistic agent in cancer chemotherapy. Frontiers in Pharmacology, 2019, 9 : 1534

[12] Lei Z , Ju Y , Lin Y . . Reactive oxygen species synergistic pH/H₂O₂-responsive poly(l-lactic acid)-block-poly(sodium 4-styrenesulfonate)/citrate-Fe(III)@ZIF-8 hybrid nanocomposites for controlled drug release. ACS Applied Bio Materials, 2019, 2( 8): 3648– 3658

[13] Lei Z , Tang Q , Ju Y . . Block copolymer@ZIF-8 nanocomposites as a pH-responsive multi-steps release system for controlled drug delivery. Journal of Biomaterials Science: Polymer Edition, 2020, 31( 6): 695– 711

[14] Wang Y , Cheng S , Hu W . . Polymer-grafted hollow mesoporous silica nanoparticles integrated with microneedle patches for glucose-responsive drug delivery. Frontiers of Materials Science, 2021, 15( 1): 98– 112

[15] Minchinton A I , Tannock I F . Drug penetration in solid tumours. Nature Reviews Cancer, 2006, 6( 8): 583– 592

[16] Kelland L . The resurgence of platinum-based cancer chemotherapy. Nature Reviews Cancer, 2007, 7( 8): 573– 584

[17] Holohan C , Van Schaeybroeck S , Longley D B . . Cancer drug resistance: an evolving paradigm. Nature Reviews Cancer, 2013, 13( 10): 714– 726

[18] Siddik Z H . Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene, 2003, 22( 47): 7265– 7279

[19] Gottesman M M . Mechanisms of cancer drug resistance. Annual Review of Medicine, 2002, 53( 1): 615– 627

[20] Tong Z , Zhou J , Huang R . . Dual-responsive supramolecular self-assembly of inclusion complex of an azobenzene-ended poly(ε-caprolactone) with a water-soluble pillar[6]arene and its application in controlled drug release. Journal of Polymer Science Part A: Polymer Chemistry, 2017, 55( 15): 2477– 2482

[21] He H , Zhou J , Liu Y . . Near-infrared-light-induced morphology transition of poly(ether amine) nanoparticles for supersensitive drug release. ACS Applied Materials & Interfaces, 2018, 10( 8): 7413– 7421

[22] Zhou J , Xu H , Tong Z . . Photo/pH-controlled host-guest interaction between an azobenzene-containing block copolymer and water-soluble pillar[6]arene as a strategy to construct the “compound vesicles” for controlled drug delivery. Materials Science and Engineering C, 2018, 89 : 237– 244

[23] Mekaru H , Lu J , Tamanoi F . Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy. Advanced Drug Delivery Reviews, 2015, 95 : 40– 49

[24] Hu X , Yu J , Qian C . . H₂O₂-responsive vesicles integrated with transcutaneous patches for glucose-mediated insulin delivery. ACS Nano, 2017, 11( 1): 613– 620

[25] Xiang Z , Liu M , Song J . Stimuli-responsive polymeric nanosystems for controlled drug delivery. Applied Sciences, 2021, 11( 20): 9541

[26] Tong Z , Zhou J , Zhong J . . Glucose- and H₂O₂-responsive polymeric vesicles integrated with microneedle patches for glucose-sensitive transcutaneous delivery of insulin in diabetic rats. ACS Applied Materials & Interfaces, 2018, 10( 23): 20014– 20024

[27] Tiefenboeck P , Kim J A , Trunk F . . Comment on “A liposomal system capable of generating CO₂ bubbles to induce transient cavitation, lysosomal rupturing and cell necrosis”. Angewandte Chemie International Edition, 2017, 56( 39): 11686– 11689

[28] Qu J , Zhao X , Ma P X . . Injectable antibacterial conductive hydrogels with dual response to an electric field and pH for localized “smart” drug release. Acta Biomaterialia, 2018, 72 : 55– 69

[29] Petros R A , DeSimone J M . Strategies in the design of nanoparticles for therapeutic applications. Nature Reviews Drug Discovery, 2010, 9( 8): 615– 627

[30] Brigger I , Dubernet C , Couvreur P . Nanoparticles in cancer therapy and diagnosis. Advanced Drug Delivery Reviews, 2002, 54( 5): 631– 651

[31] Song G , Sun Y , Liu T . . Transdermal delivery of Cu-doped polydopamine using microneedles for photothermal and chemodynamic synergistic therapy against skin melanoma. Chemical Engineering Journal, 2021, 426 : 130790

[32] Yang J , Yu X , Song J I . . Aggregation-induced emission featured supramolecular tubisomes for imaging-guided drug delivery. Angewandte Chemie International Edition, 2022, 61( 9): e202115208

[33] Yang J , Yu G , Sessler J L . . Artificial transmembrane ion transporters as potential therapeutics. Chem, 2021, 7( 12): 3256– 3291

[34] Yang J , Song J I , Song Q . . Hierarchical self-assembled photo-responsive tubisomes from a cyclic peptide-bridged amphiphilic block copolymer. Angewandte Chemie International Edition in English, 2020, 59( 23): 8860– 8863

[35] Ke W , Yin W , Zha Z . . A robust strategy for preparation of sequential stimuli-responsive block copolymer prodrugs via thiolactone chemistry to overcome multiple anticancer drug delivery barriers. Biomaterials, 2018, 154 : 261– 274

[36] Iqbal S , Zhao Z . Poly (β amino esters) copolymers: novel potential vectors for delivery of genes and related therapeutics. International Journal of Pharmaceutics, 2022, 611 : 121289

[37] Du Y , Chen W , Zheng M . . pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride. Biomaterials, 2012, 33( 29): 7291– 7299

[38] Padmavathy N , Das Ghosh L , Meka S R K . . Synthesis of a block copolymer exhibiting cell-responsive phytochemical release for cancer therapy. ACS Applied Materials & Interfaces, 2018, 10( 26): 21816– 21824

[39] Yang C , Jeong S , Ku S . . Use of gasotransmitters for the controlled release of polymer-based nitric oxide carriers in medical applications. Journal of Controlled Release, 2018, 279 : 157– 170

[40] Zheng H , Li X , Jia Q . Design of pH-responsive polymer monolith based on cyclodextrin vesicle for capture and release of myoglobin. ACS Applied Materials & Interfaces, 2018, 10( 6): 5909– 5917

[41] Lv S , Wu Y , Cai K . . High drug loading and sub-quantitative loading efficiency of polymeric micelles driven by donor–receptor coordination interactions. Journal of the American Chemical Society, 2018, 140( 4): 1235– 1238

[42] Li Z , Bin Luo , Yu L . . Intermolecular B-N coordination and multi-interaction synergism induced selective glycoprotein adsorption by phenylboronic acid-functionalized magnetic composites under acidic and neutral conditions. Journal of Materials Chemistry B: Materials for Biology and Medicine, 2021, 9( 2): 453– 463

[43] Oide Y , Iwasaki M , Yoshida K . . Preparation of multilayer films using the negative charge of phenylboronic acid and its response to pH change, fructose, and hydrogen peroxide. Colloid & Polymer Science, 2018, 296( 9): 1573– 1580

[44] Zheng H , Zhang Y , Liu L . . One-pot synthesis of metal-organic frameworks with encapsulated target molecules and their applications for controlled drug delivery. Journal of the American Chemical Society, 2016, 138( 3): 962– 968

[45] Zheng X , Wang L , Pei Q . . Metal-organic framework@porous organic polymer nanocomposite for photodynamic therapy. Chemistry of Materials, 2017, 29( 5): 2374– 2381

[46] Zhou H C , Long J R , Yaghi O M . Introduction to metal-organic frameworks. Chemical Reviews, 2012, 112( 2): 673– 674

[47] Huang H , Li J R , Wang K . . An in situ self-assembly template strategy for the preparation of hierarchical-pore metal-organic frameworks. Nature Communications, 2015, 6( 1): 8847

[48] Cao S , Gody G , Zhao W . . Hierarchical bicontinuous porosity in metal-organic frameworks templated from functional block co-oligomer micelles. Chemical Science, 2013, 4( 9): 3573– 3577

[49] Wu M X , Yang Y W . Metal-organic framework (MOF)-based drug/cargo delivery and cancer therapy. Advanced Materials, 2017, 29( 23): 1606134

[50] Lian X , Fang Y , Joseph E . . Enzyme-MOF (metal-organic framework) composites. Chemical Society Reviews, 2017, 46( 11): 3386– 3401

[51] Brauman J I . Frontiers in materials science. Science, 1992, 255( 5048): 1049

[52] Ettlinger R , Moreno N , Volkmer D . . Zeolitic imidazolate framework-8 as pH-sensitive nanocarrier for “arsenic trioxide” drug delivery. Chemistry: A European Journal, 2019, 25( 57): 13189– 13196

[53] Banerjee R , Furukawa H , Britt D . . Control of pore size and functionality in isoreticular zeolitic imidazolate frameworks and their carbon dioxide selective capture properties. Journal of the American Chemical Society, 2009, 131( 11): 3875– 3877

[54] Lu Z , Knobler C B , Furukawa H . . Synthesis and structure of chemically stable metal-organic polyhedra. Journal of the American Chemical Society, 2009, 131( 35): 12532– 12533

[55] Zheng C , Wang Y , Phua S Z F . . ZnO–DOX@ZIF-8 core–shell nanoparticles for pH-responsive drug delivery. ACS Biomaterials Science & Engineering, 2017, 3( 10): 2223– 2229

RIGHTS & PERMISSIONS

Higher Education Press